ANTI-CD19 COMBINATION THERAPY Application WO-2022117799-A2 World Intellectual Property Organisation (WIPO) 09 Jun 2022
Diagnosis and treatment of lymphoproliferative disorders with PARP inhibitors Grant US-11311537-B2 United States of America 26 Apr 2022
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Grant US-10400043-B2 United States of America 03 Sep 2019
Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody Grant US-10113000-B2 United States of America 30 Oct 2018